Last price paid | 0.19 | |
Change | +5.56% [ +0.01 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 06.06.2024 17:20 |
Fixing | n.a. |
Settlement date | 15.05.2023 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +62.50% |
Year to date (YTD) | -42.42% |
1 month | -17.39% |
3 months | -36.67% |
1 year | +35.71% |
3 years | n.a. |
Issue price | 0.12 |
Underlying price on issue | 46.20 |
Premium | 0.04% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1250732992 |
Symbol | IBSWEZ |
Security | 125073299 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Basilea Pharmaceu N, CH0011432447 |
Underlying ISIN | CH0011432447 |
Funding level | 50.049300 |
Stop-loss level | 48.070500 |
Distance to stop-loss level | 14.86% |
Long/Short type | Short |
Subscription ratio | 50.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 11.05.2023 |
Premium | 3.71% |
Premium p.a. | n.a. |
Leverage | 4.29 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 8.199300 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
Givaudan | 4'362.00 |
Holcim | 80.46 |
GEBERIT N | 551.80 |
Lonza Group | 501.00 |
ABB Ltd | 50.36 |
Name | Price |
---|---|
Nestlé SA | 95.60 |
UBS | 28.03 |
Swiss Re | 112.25 |
ROCHE GS | 239.70 |
Compagnie Financi... | 148.55 |